Teva and Jiangsu Nhwa Forge Strategic Partnership to Promote Patient Access to AUSTEDO® in ChinaBusiness Wire • 02/26/24
Teva Presents New Data Supporting Safety, Tolerability and Target Engagement of Anti-TL1A (TEV-‘574) Antibody at the 2024 ECCO Annual MeetingBusiness Wire • 02/20/24
Teva Canada Named by Forbes as No. 1 Canadian Employer in Drugs & Biotechnology IndustryBusiness Wire • 02/07/24
MedinCell's Partner Teva Provides Guidance for UZEDY in 2024 and an Update on the Treatment-Candidate of Olanzapine Long-Acting Injectable (LAI)Business Wire • 01/31/24
Teva Pharmaceutical Industries Ltd. (TEVA) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 01/31/24
Teva Sinks On Lackluster Profit Outlook Despite Walloping Quarterly ProjectionsInvestors Business Daily • 01/31/24
Teva Announces Intention to Divest API Business as Part of Pivot to Growth StrategyBusiness Wire • 01/31/24
Unveiling Teva Pharmaceutical Industries Ltd. (TEVA) Q4 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 01/26/24
Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology SpaceInvestors Business Daily • 01/12/24
MedinCell's partner Teva Announces Recruitment Completion of Phase 3 Clinical Study of mdc-TJK / Olanzapine Long-Acting Injectable (LAI)Business Wire • 01/09/24
Teva Pharmaceutical Industries Limited (TEVA) Presents at J.P. Morgan 42nd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 01/09/24
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024Business Wire • 01/02/24
Corcept Therapeutics shares sink after losing patent infringement lawsuit against TevaProactive Investors • 01/02/24